Studies in animal models have shown that Plumbagin successfully inhibited breast cancer cell metastasis and osteolysis by significantly altering the RANKL/OPG ratio in osteoblasts (189) (Figure 2). This evidence concerns the gene TNFSF11 and breast carcinoma.